AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- Open
- $502.29
- 52-wk high
- $609.35
- High
- $509.54
- 52-wk low
- $302.19
- Low
- $499.96
- Prev close
- $521.00
Smart money
Earnings
Earnings came in 6.6% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $799.5M | $790.2M | $781.5M | $783.3M |
| Cost of what it sold | $100.9M | $103.4M | $133.4M | $99.5M |
| Gross profit | $698.6M | $686.8M | $648.1M | $683.8M |
| What it spent | ||||
| Research and development | $127.5M | $139.5M | $138.2M | $146.3M |
| Sales and admin | $153.5M | $157.1M | $155.4M | $137.9M |
| Other operating costs | $28.3M | $32.7M | $28.7M | $68.8M |
| Total operating expenses | $309.3M | $329.3M | $322.3M | $353.0M |
| What was left | ||||
| Operating profit | $389.3M | $357.5M | $325.8M | $330.8M |
| Interest on debt | $3.0M | $3.1M | $3.0M | $2.9M |
| Profit before tax | $438.0M | $444.0M | $318.3M | $372.7M |
| Tax | $99.3M | $79.7M | $43.4M | $39.7M |
| Net profit | $338.7M | $364.3M | $274.9M | $333.0M |
| EBITDA | $462.9M | $469.9M | $343.9M | $375.6M |
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
41balanced
20D volatility
21%annualized
52-week range
$302.19$609.35
20D support
News
What the news says
15 articles · 7 days
Coverage leans bearish
Tone of tracked coverage
United Therapeutics (UTHR) CEO sells shares under preset trading plan
NeutralAug 20ETFs Investing in United Therapeutics Corporation Stocks
NeutralAug 19United Therapeutics (NASDAQ: UTHR) CEO sells 9,500 shares
NeutralAug 18
